For: | Jiang Y, Yim SH, Xu HD, Jung SH, Yang SY, Hu HJ, Jung CK, Chung YJ. A potential oncogenic role of the commonly observed E2F5 overexpression in hepatocellular carcinoma. World J Gastroenterol 2011; 17(4): 470-477 [PMID: 21274376 DOI: 10.3748/wjg.v17.i4.470] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v17/i4/470.htm |
Number | Citing Articles |
1 |
Lina Li, Jie Liu, Wei Huang. E2F5 promotes proliferation and invasion of gastric cancer through directly upregulating UBE2T transcription. Digestive and Liver Disease 2022; 54(7): 937 doi: 10.1016/j.dld.2021.09.003
|
2 |
Qi He, Bo Zhang, Feng Hu, Jianwen Long, Quan Shi, Xianming Pi, Hongxiang Chen, Jiawen Li. <p>Triptolide Inhibits the Proliferation of HaCaT Cells Induced by IL22 via Upregulating miR-181b-5p</p>. Drug Design, Development and Therapy 2020; : 2927 doi: 10.2147/DDDT.S254466
|
3 |
Ying Xie, Xiaofeng Hang, Wensheng Xu, Jing Gu, Yuanjing Zhang, Jianrong Wang, Xiucui Zhang, Xinghao Cao, Junjie Zhan, Junxue Wang, Jianhe Gan. CircFAM13B promotes the proliferation of hepatocellular carcinoma by sponging miR-212, upregulating E2F5 expression and activating the P53 pathway. Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02120-6
|
4 |
ELIZABETH ROSE HELLER, ANKIT GOR, DAN WANG, QIANG HU, ALBERTA LUCCHESE, DARJA KANDUC, MEENA KATDARE, SONG LIU, ANIMESH A. SINHA. Molecular signatures of basal cell carcinoma susceptibility and pathogenesis: A genomic approach. International Journal of Oncology 2013; 42(2): 583 doi: 10.3892/ijo.2012.1725
|
5 |
Lu Wang, Yifan Chen, Rao Chen, Fengbiao Mao, Zhongsheng Sun, Xiangdong Liu. Risk modeling of single-cell transcriptomes reveals the heterogeneity of immune infiltration in hepatocellular carcinoma. Journal of Biological Chemistry 2023; 299(3): 102948 doi: 10.1016/j.jbc.2023.102948
|
6 |
Shika Hanif Malgundkar, Ikram Burney, Mansour Al Moundhri, Moza Al Kalbani, Ritu Lakhtakia, Aikou Okamoto, Yahya Tamimi. E2F5 Promotes the Malignancy of Ovarian Cancer Via the Regulation of Hippo and Wnt Pathways. Genetic Testing and Molecular Biomarkers 2021; 25(3): 179 doi: 10.1089/gtmb.2020.0166
|
7 |
Parisa Naeli, Mohammad Hossein Pourhanifeh, Mohammad Reza Karimzadeh, Zahra Shabaninejad, Ahmad Movahedpour, Hossein Tarrahimofrad, Hamid Reza Mirzaei, Hassan Hassani Bafrani, Amir Savardashtaki, Hamed Mirzaei, Michael R. Hamblin. Circular RNAs and gastrointestinal cancers: Epigenetic regulators with a prognostic and therapeutic role. Critical Reviews in Oncology/Hematology 2020; 145: 102854 doi: 10.1016/j.critrevonc.2019.102854
|
8 |
Kun Xu, Ting Ting Zhang, Ling Wang, Cun Fang Zhang, Long Zhang, Li Xia Ma, Ying Xin, Chong Hua Ren, Zhi Qiang Zhang, Qiang Yan, Daniel Martineau, Zhi Ying Zhang. Walleye dermal sarcoma virus: expression of a full-length clone or the rv-cyclin (orf a) gene is cytopathic to the host and human tumor cells. Molecular Biology Reports 2013; 40(2): 1451 doi: 10.1007/s11033-012-2188-5
|
9 |
Ying Liu, Donghai Liu, Wuqing Wan. MYCN-induced E2F5 promotes neuroblastoma cell proliferation through regulating cell cycle progression. Biochemical and Biophysical Research Communications 2019; 511(1): 35 doi: 10.1016/j.bbrc.2019.01.087
|
10 |
Young-Sik Kim, Jiyoon Jung, Hoiseon Jeong, Hwa Eun Oh, Ju-Han Lee, Eung Seok Lee, Jung-Woo Choi. Protein expression profiles and prognostic value of E2F family members in clear cell renal cell carcinoma. Pathology - Research and Practice 2020; 216(4): 152880 doi: 10.1016/j.prp.2020.152880
|
11 |
Zhilu Gan, Alimujiang Abudurexiti, Xiaogang Hu, Wenxin Chen, Ning Zhang, Wei Sang. E2F3/5/8 serve as potential prognostic biomarkers and new therapeutic direction for human bladder cancer. Medicine 2024; 103(2): e35722 doi: 10.1097/MD.0000000000035722
|
12 |
Konstantinos Evangelou, Sophia Havaki, Athanassios Kotsinas. E2F transcription factors and digestive system malignancies: How much do we know?. World Journal of Gastroenterology 2014; 20(29): 10212-10216 doi: 10.3748/wjg.v20.i29.10212
|
13 |
Limei Wang, Jin Li, Enze Liu, Garrett Kinnebrew, Xiaoli Zhang, Daniel Stover, Yang Huo, Zhi Zeng, Wanli Jiang, Lijun Cheng, Weixing Feng, Lang Li. Identification of Alternatively-Activated Pathways between Primary Breast Cancer and Liver Metastatic Cancer Using Microarray Data. Genes 2019; 10(10): 753 doi: 10.3390/genes10100753
|
14 |
Jiaqi Sheng, Yiming Luo, Enjun Lv, Huifang Liang, Haisu Tao, Chengpeng Yu, Dean Rao, Mengyu Sun, Limin Xia, Wenjie Huang. LINC01980 induced by TGF-beta promotes hepatocellular carcinoma metastasis via miR-376b-5p/E2F5 axis. Cellular Signalling 2023; 112: 110923 doi: 10.1016/j.cellsig.2023.110923
|
15 |
Elham Farhadi, Mohammadreza Khomeijani-Farahani, Rambod Nikbakhsh, Amin Azizan, Samaneh Soltani, Hassan Barekati, Mahdi Mahmoudi. The potential role of circular RNAs in regulating p53 in different types of cancers. Pathology - Research and Practice 2024; 261: 155488 doi: 10.1016/j.prp.2024.155488
|
16 |
Ji Sun, Hong Li, Qi Huo, Meiling Cui, Chao Ge, Fangyu Zhao, Hua Tian, Taoyang Chen, Ming Yao, Jinjun Li. The transcription factor FOXN3 inhibits cell proliferation by downregulating E2F5 expression in hepatocellular carcinoma cells. Oncotarget 2016; 7(28): 43534 doi: 10.18632/oncotarget.9780
|
17 |
Fengrong Sun, Cuiping Zhang, Deliang Ma, Kai Wang. MicroRNA‑544 inhibits esophageal squamous cell carcinoma cell proliferation and enhances sensitivity to cisplatin by repressing E2F transcription factor 5. Oncology Letters 2019; doi: 10.3892/ol.2019.10749
|
18 |
Justin T. Huntington, Xing Tang, Lindsey N. Kent, Carl R. Schmidt, Gustavo Leone. The Spectrum of E2F in Liver Disease-Mediated Regulation in Biology and Cancer. Journal of Cellular Physiology 2016; 231(7): 1438 doi: 10.1002/jcp.25242
|
19 |
Lina Li, Cuiling Wu, Yue Zhao. miRNA-34a enhances the sensitivity of gastric cancer cells to treatment with paclitaxel by targeting E2F5. Oncology Letters 2017; 13(6): 4837 doi: 10.3892/ol.2017.6041
|
20 |
Sun-Hee Jang, Yuzhu Jiang, Sun Shin, Seung-Hyun Jung, Chan Kwon Jung, Yeun-Jun Chung. Potential Oncogenic Role of the Papillary Renal Cell Carcinoma Gene in Non-Small Cell Lung Cancers. Yonsei Medical Journal 2019; 60(4): 326 doi: 10.3349/ymj.2019.60.4.326
|
21 |
Nasrin Ahangar Davoodi, Sajad Najafi, Zari Naderi Ghale-Noie, Ashkan Piranviseh, Samaneh Mollazadeh, Sahar Ahmadi Asouri, Zatollah Asemi, Mohammadamin Morshedi, Seyed Saeed Tamehri Zadeh, Michael R. Hamblin, Amirhossein Sheida, Hamed Mirzaei. Role of non-coding RNAs and exosomal non-coding RNAs in retinoblastoma progression. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.1065837
|
22 |
Xia Yang, Han‑Lin Wang, Hai‑Wei Liang, Liang Liang, Dong‑Yue Wen, Rui Zhang, Gang Chen, Dan‑Ming Wei. Clinical significance of microRNA-449a in hepatocellular carcinoma with microarray data mining together with initial bioinformatics analysis. Experimental and Therapeutic Medicine 2018; doi: 10.3892/etm.2018.5836
|
23 |
Chao Han, Nicole A. Seebacher, Francis J. Hornicek, Quancheng Kan, Zhenfeng Duan. Regulation of microRNAs function by circular RNAs in human cancer. Oncotarget 2017; 8(38): 64622 doi: 10.18632/oncotarget.19930
|
24 |
Zafar Abbas Shah, Faisal Nouroz, Asima Tayyeb. In silico BRCA1 pathway analysis in breast invasive carcinoma. MGM Journal of Medical Sciences 2021; 8(1): 44 doi: 10.4103/mgmj.mgmj_88_20
|
25 |
Yiting Zhang, Xinyue Zhu, Xiaomin Zhu, Yan Wu, Yajun Liu, Borui Yao, Zhenping Huang. MiR-613 suppresses retinoblastoma cell proliferation, invasion, and tumor formation by targeting E2F5. Tumor Biology 2017; 39(3): 101042831769167 doi: 10.1177/1010428317691674
|
26 |
Carson D. Broeker, Eran R. Andrechek. Comprehensive Pharmacology. 2022; : 277 doi: 10.1016/B978-0-12-820472-6.00102-X
|
27 |
L. H. Zhu, J. X. Xu, S. W. Zhu, X. Cai, S. F. Yang, X. L. Chen, Q. Guo. Gene expression profiling analysis reveals weaning-induced cell cycle arrest and apoptosis in the small intestine of pigs1. Journal of Animal Science 2014; 92(3): 996 doi: 10.2527/jas.2013-7551
|
28 |
Wei Du, Xueming Xia, Qiheng Gou, Yuxin Xie, Lanyang Gao. Comprehensive review regarding the association of E2Fs with the prognosis and immune infiltrates in human head and neck squamous cell carcinoma. Asian Journal of Surgery 2024; 47(5): 2106 doi: 10.1016/j.asjsur.2024.01.130
|
29 |
Zikang Zhang, Qing Xie, Dongmei He, Yuan Ling, Yuchao Li, Jiangbin Li, Hua Zhang. Circular RNA: new star, new hope in cancer. BMC Cancer 2018; 18(1) doi: 10.1186/s12885-018-4689-7
|
30 |
Yujia Lu, Wei Li. Functional characterization of E2F3b in human HepG2 liver cancer cell line. Journal of Cellular Biochemistry 2018; 119(4): 3429 doi: 10.1002/jcb.26513
|
31 |
Huijun Xie, Xiaoli Ren, Sainan Xin, Xiaoliang Lan, Guifeng Lu, Yuan Lin, Shaoshan Yang, Zhicheng Zeng, Wenting Liao, Yan-Qing Ding, Li Liang. Emerging roles of circRNA_001569 targeting miR-145 in the proliferation and invasion of colorectal cancer. Oncotarget 2016; 7(18): 26680 doi: 10.18632/oncotarget.8589
|
32 |
Dingtao Hu, Nana Meng, Xiaoqi Lou, Zhen Li, Ying Teng, Bizhi Tu, Yanfeng Zou, Fang Wang. Prognostic Values of E2F1/2 Transcriptional Expressions in Chromophobe Renal Cell Carcinoma Patients: Evidence from Bioinformatics Analysis. International Journal of General Medicine 2021; : 3593 doi: 10.2147/IJGM.S321585
|
33 |
Lu Wang, Yifan Chen, Fengbiao Mao, Zhongsheng Sun, Xiangdong Liu. Risk Modelling of Single Cell Populations Revealed the Heterogeneity of Immune Infiltration in Hepatocellular Carcinoma. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4109529
|
34 |
Briana To, Carson Broeker, Jing-Ru Jhan, Jesus Garcia-Lerena, John Vusich, Rachel Rempel, Jonathan P. Rennhack, Daniel Hollern, Lauren Jackson, David Judah, Matt Swiatnicki, Evan Bylett, Rachel Kubiak, Jordan Honeysett, Joseph Nevins, Eran Andrechek. Insight into mammary gland development and tumor progression in an E2F5 conditional knockout mouse model. Oncogene 2024; 43(46): 3402 doi: 10.1038/s41388-024-03172-4
|
35 |
Bhavneet Bhinder, Christophe Antczak, Christina N. Ramirez, David Shum, Nancy Liu-Sullivan, Constantin Radu, Mark G. Frattini, Hakim Djaballah. An Arrayed Genome-Scale Lentiviral-Enabled Short Hairpin RNA Screen Identifies Lethal and Rescuer Gene Candidates. ASSAY and Drug Development Technologies 2013; 11(3): 173 doi: 10.1089/adt.2012.475
|
36 |
Mahmoud ElHefnawi, Bangli Soliman, Nourhan Abu-Shahba, Marwa Amer. An Integrative Meta-Analysis of MicroRNAs in Hepatocellular Carcinoma. Genomics, Proteomics & Bioinformatics 2013; 11(6): 354 doi: 10.1016/j.gpb.2013.05.007
|
37 |
Lei Zhan, Cheng Huang, Xiao Ming Meng, Yang Song, Xiao Qin Wu, Cheng Gui Miu, Xiang Shu Zhan, Jun Li. Promising roles of mammalian E2Fs in hepatocellular carcinoma. Cellular Signalling 2014; 26(5): 1075 doi: 10.1016/j.cellsig.2014.01.008
|
38 |
Ziqiu Jia, Zhao Jin, Meiqi Li, Xin Zhang, Min Peng, Shanshan Zhang, Ming Tan, Qingzhu Yang, Weiyu Wang, Yingning Sun. E2F transcription factor 5, a new regulator in adipogenesis to mediate the role of Krüppel-like factor 7 in chicken preadipocyte differentiation and proliferation. Poultry Science 2024; 103(6): 103728 doi: 10.1016/j.psj.2024.103728
|
39 |
Subhadipa Majumder, Ankur Bhowal, Sanmitra Basu, Pritha Mukherjee, Urmi Chatterji, Sanghamitra Sengupta. Deregulated E2F5/p38/SMAD3 Circuitry Reinforces the Pro-Tumorigenic Switch of TGFβ Signaling in Prostate Cancer. Journal of Cellular Physiology 2016; 231(11): 2482 doi: 10.1002/jcp.25361
|